New compounds targeting the pathways critical to end-organ damage and cancer

CCRP Therapeutics is a biopharmaceutical spin-off of Charité's Center for Cardiovascular Research (CCR).

The company's focus is the discovery of breakthrough drugs in indications with common pathophysiological mechanisms and high unmet medical need. In collaboration with major pharmaceutical companies innovative therapeutic approaches will be further advanced and commercialized.